Iacog News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Iacog. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Iacog Today - Breaking & Trending Today

FAK Inhibition Emerges as a Potential Complementary Treatment Pathway

Although FAK inhibition alone has displayed modest activity to date, there is interest in developing FAK-targeted therapies for combination regimens. ....

New York , United States , West Palm Beach , Memorial Sloan Kettering Cancer Center , Racheln Grisham , Asia Pacific , Davidm Omalley , Department Of Obstetrics , Ohio State University College Of Medicine , Florida Cancer Specialists Research Institute , Drug Development Summit , Gynecologic Oncology Group Study , Onclive News Network Program , Ohio State University Comprehensive Cancer Center , American Society Of Clinical Oncology Annual Meeting , Division Of Gynecologic Oncology , Combination Component , Ovarian Cancer , Florida Cancer Specialists , Research Institute , Ohio State University College , Gynecologic Oncology , Onclive News Network , Targeted Drug Development Summit , Clinical Oncology Annual Meeting , Gynecologic Oncology Group ,

Dr Westin on Early Findings With Azenosertib in High-Grade Serous Ovarian Cancer

Shannon N. Westin, MD, MPH, FACOG, discusses the DENALI trial of azenosertib
in patients with high-grade serous ovarian cancer. ....

United States , Shannonn Westin , Division Of Surgery , University Of Texas Md Anderson Cancer Center , Department Of Gynecologic Oncology , Early Drug Development , Ovarian Cancer Moonshot Program , Gynecologic Oncology , Reproductive Medicine , Cancer Center , Denali Trial , Patients With High Grade Serous Ovarian Cancer ,

Journey Ends for Upifitamab Rilsodotin in NaPi2b+ Platinum-Resistant Ovarian Cancer

Debra L. Richardson, MD, FACS, FACOG, expands on results with upifitamab rilsodotin in platinum-resistant high-grade serous ovarian cancer. ....

University Of Oklahoma , United States , Oklahoma City , Debral Richardson , Phasei Program , Ou Health , Stephenson Cancer Center , University Of Oklahoma Ou College Medicine , Gynecologic Oncology , Upifitamab Rilsodotin , Platinum Resistant High Grade Serous Ovarian Cancer , The University Of Oklahoma College Medicine ,

Modesitt Spotlights the Latest ADC Breakthroughs in Gynecologic Oncology

Susan C. Modesitt, MD, FACOG, FACS, sheds light on the latest research with antibody-drug conjugates across gynecologic cancers. ....

Emory University , United States , Susanc Modesitt , National Comprehensive Cancer Network , Winship Cancer Institute Of Emory University , Onclive State , Science Summit , Winship Cancer Institute , Gynecologic Oncology , Emory University School , Antibody Drug Conjugates , Onclive State Of The Science Summit , Trop2 And Her2 Targeted Adcs , Minimizing Toxicities , Mirvetuximab Soravtansine , Trastuzumab Deruxtecan , Sacituzumab Govitecan , Tisotumab Vedotin ,

The Role of Genetics in Cancer Care Continues to Expand

Genetic screening and testing have only recently become an integral part of cancer care. ....

New York , United States , Barack Obama , Montefiore Einstein , Susand Klugman , Angelina Jolie , Mary Claire King , Department Of Obstetrics , York Breast Cancer Study Group , Division Of Reproductive , Women Health , New York Times , National Institutes Of Health , American College Of Medical Genetics , Montefiore Einstein Comprehensive Cancer Center , National Comprehensive Cancer Network , Precision Medicine Initiative , Genetic Information Nondiscrimination Act , Star Shapes , Genetic Testing , President Barack Obama , National Institutes , Medical Genetics , Montefiore Health System , Albert Einstein College , American College ,